White Papers
-
2025 Safety And Regulatory Compliance Trends And Predictions
12/16/2024
Explore the rapidly evolving regulatory landscape that pharmaceutical and biotech industries face as they integrate AI and advanced technologies into safety, compliance, and lifecycle management.
-
Ensuring A Diverse Patient Population In Clinical Trials
12/13/2024
In 2025, the FDA will require pharmaceutical companies to include diversity action plans (DAPs) for Phase II and pivotal studies.
-
Vaccine Clinical Trials Global Landscape Whitepaper (2024)
12/5/2024
The global vaccine trial landscape is undergoing rapid evolution, driven by technological innovations, emerging health threats, and regulatory shifts.
-
The Evolution Of SDV, SDR, And RBQM In Clinical Trial Data Quality
11/18/2024
Explore the inefficiency of complete SDV and how the adoption of technologies like centralized monitoring, remote SDR, and targeted SDV can enhance data integrity and cost-effectiveness.
-
Preparing CRAs For Success In Oncology: Targeted Training In An Era Of Advanced Therapeutics
11/18/2024
Explore the pivotal role of Clinical Research Associates (CRAs) in oncology clinical trials, emphasizing their critical responsibilities and the importance of specialized CRA training programs.
-
Patient Diaries Done Right: A Blueprint For Success
11/18/2024
Discover how patient diaries can improve data quality and engagement, as well as best practices to design, deploy, and monitor diaries that work for both participants and researchers.
-
Bladder Cancer Global Clinical Trial Landscape (2024)
11/12/2024
Bladder cancer is the ninth most common cancer in the world and thirteenth in mortality. This report provides a detailed overview of the clinical trial landscape for bladder cancer.
-
Practical Strategies For Diverse Trial Recruitment
11/11/2024
The clock is ticking on the requirement for pharmaceutical companies to include FDA-mandated diversity action plans for pivotal studies in clinical trials.
-
The Rapid Digitization Of Trials
11/7/2024
It’s no secret that more trials are going digital. Hear from a panel of industry experts including Sanofi, Bayer, and the Clinical Trials Transformation Initiative (CTTI) as they discuss the evolution of digital trials and share their experiences.
-
The Impact Of High Inflation And The Great Resignation On Clinical Site Budgeting
10/30/2024
The twin pressures of inflation and attrition prolong negotiations between sponsors and clinical sites, stalling drug development. Sponsors need up-to-date, reliable benchmark data to negotiate fair market value budgets.